People's accounts / changes felt and changes measured
Sermorelin reports describe experiences that still need testing.
Sermorelin can raise growth hormone. This page compares people's accounts with human study findings. A change after use doesn't establish that a change was caused by the drug.
What would help a Sermorelin account establish a benefit
Sermorelin copies growth hormone-releasing hormone, which starts the gland's release of growth hormone. This page looks at reports of changes and the evidence those reports lack. The drug's action can make sleep and energy claims sound possible. Finding out whether someone benefited still needs a proper test.
For you, a useful account says whether anyone measured the change. A comparison with people given no drug helps test the cause. The number who noticed no change matters too. Diet, sleep, and activity can change how someone feels. The tested drug also matters: sermorelin and related drugs aren't interchangeable. People describe sleep, energy, recovery, fat, skin, muscles, and unwanted effects. Human studies have checked narrower concerns, including blood sugar and reactions to shots. Some studies also tested how the gland responds to continuous drug delivery. Lasting benefits and cancer risk remain unanswered.
The personal experiences below describe changes without establishing their cause.
What Sermorelin users describe, without a trial to check the cause
These accounts come from users who say they used Sermorelin for research. The accounts aren't controlled study findings. A trial hasn't checked whether Sermorelin caused the reported changes. The accounts don't reliably show whether a doctor gave shots, someone used the drug alone, or someone joined research. The phrases below describe repeated mentions, with no report counts or user totals given. Words such as often therefore can't tell you how many people had a change.
What people described as benefits. Vivid dreams and deeper sleep appear very often in accounts. The number of users who slept better isn't given. More daytime energy and feeling recovered appear often in accounts, sometimes alongside better sleep. What the people were recovering from is unclear. Gradual fat loss appears often in accounts, while diet and activity could change too. Small changes, slow changes, and no clear change also appear often in accounts. Firmer muscles, a change in skin feel, and feeling better appear sometimes in accounts. Those changes are personal impressions.
What people described as unwanted effects. Itching, redness, and swelling at the shot spot appear very often in accounts. Headache, upset stomach, flushing, and dizziness appear often in accounts. Flushing means skin briefly feels hot and looks red. Puffiness appears sometimes in accounts. Greater appetite appears sometimes in accounts. Sleepiness or grogginess appears sometimes in accounts. Hand tingling or numbness appears rarely in accounts. Higher blood sugar appears rarely in accounts from people whose blood sugar was already more likely to rise. The timing after a shot doesn't prove the shot caused the change. A doubtful label leaves the drug's identity unclear as well.
What the accounts leave missing. Ten accounts from dozens of users differ greatly from ten accounts among thousands. Similar wording may be repeated on discussion websites, where users post messages, and on clinic or review pages. No individual accounts are shown here, so you can't check whether different people wrote them. Wrong labels or unwanted substances may mean a product wasn't sermorelin. Feeling better after treatment doesn't establish what would have happened without treatment. A short account can't answer questions about harm over years.
Someone's experience can matter without proving what the drug did.
Which drugs produced the safety findings people ask about
Lasting adult benefit: Large trials lasting years are missing. An opinion in Annals judged the proof too weak to treat aging with hormone-raising drugs. [9]
Cancer: Insulin-like growth factor is a liver hormone that encourages cell growth, as growth hormone does. That action raises a possible cancer concern still unresolved by long safety studies. These findings haven't established that sermorelin causes cancer. [1]
Blood sugar: Older people received growth hormone-releasing hormone joined to polyethylene glycol, a chemical that prolongs the drug's action. Some had poorer sugar control after repeated doses. The drug wasn't sermorelin or tesamorelin. [16]
Shots and blood fats: Children given sermorelin had mild irritation at shot spots. [17] Older adults received growth hormone-releasing hormone with one protein part replaced. That was neither sermorelin nor tesamorelin. Their blood fats rose temporarily and returned to earlier levels by the study's end. [18] Other children receiving sermorelin had unchanged blood fats and blood sugar. [19]
Gland response: During brief tests in short children given sermorelin or a longer growth hormone-releasing hormone, hormones linked to sexual development and milk production rose slightly for a short time. [20] Children given sermorelin in a steady liquid flow under the skin, instead of separate shots, later released less growth hormone. The summary doesn't name the equipment. [21]
Product contents: Reviews flag wrong labels, unwanted substances, and scarce safety research outside supervised care. [22] [23] [24] Sports following rules against banned performance drugs prohibit these hormone-raising drugs. Tests can detect use. [25]
What Sermorelin's medical history cannot prove about today's reports
Doctors once prescribed an FDA-approved sermorelin medicine for defined uses. Tests checked how much growth hormone a gland could release. Treatment helped children grow when growth hormone fell short or growth was poor. A trial at several centers and a review describe that medical use. [2] [26] Other studies tested hormone responses in short children, including children making too little growth hormone and children whose poor growth had no known cause. [27] [28]
US sales ended in 2008 because of the maker's business decision. Harm or failed treatment wasn't the reason for withdrawal. Doctors turned to different tests of hormone release. [29] FDA now includes the ingredient in Category 1, a list covered by its temporary pharmacy policy. Licensed pharmacies mix sermorelin for individual patient prescriptions and must follow rules for patient medicines. That listing doesn't give the mixed prescription FDA approval. [30]
The history can't verify a benefit described in someone's account. The old approval covered children's growth and hormone tests. Making a prescription today still doesn't prove lasting adult health gains for you.